Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Albiglutide on Gallbladder Emptying
NCT02496221Phase 4Completed
- Sponsor
- GSK
- Start
- Jun 2015
- Primary completion
- Oct 2015
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of albiglutide in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Jun 2015; status: completed.
02
Drugs
albiglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02496221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02496221.